FDA Drug Recalls

Recalls / Class II

Class IID-0767-2017

Product

GSH/NAC INH PV 150/50MG/ML SOLN, Inhalation Solution, 150mg/50mg/mL, Rx only, 4mL Plastic/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Affected lot / code info
Lot # t02-21-2017@111, Exp 4/23/2017

Why it was recalled

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling firm

Firm
Key Pharmacy and Compounding Center
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
530 S 336th St, Federal Way, Washington 98003-6383

Distribution

Quantity
180mL
Distribution pattern
Distributed nationwide in U.S.A., Australia and Canada.

Timeline

Recall initiated
2017-04-18
FDA classified
2017-05-17
Posted by FDA
2017-05-24
Terminated
2017-08-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0767-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.